Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Qlt Inc. patents

Patents where

Current Assignee

Name

‌

Qlt Inc.

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7998497 Nasolacrimal drainage system implants for drug therapy	Patent 7998497 was granted and assigned to Qlt Inc. on August, 2011 by the United States Patent and Trademark Office.	‌ Qlt Inc.	United States Patent and Trademark Office	7998497	August 16, 2011
‌ US Patent 8106038 Method for reducing or preventing PDT related inflammation	Patent 8106038 was granted and assigned to Qlt Inc. on January, 2012 by the United States Patent and Trademark Office.	‌ Qlt Inc.	United States Patent and Trademark Office	8106038	January 31, 2012
‌ US Patent 7504228 Integrin linked kinase modulation of monocyte activation	Patent 7504228 was granted and assigned to Qlt Inc. on March, 2009 by the United States Patent and Trademark Office.	‌ Qlt Inc.	United States Patent and Trademark Office	7504228	March 17, 2009
‌ US Patent 7264629 Photodynamic therapy for the treatment of hair loss	Patent 7264629 was granted and assigned to Qlt Inc. on September, 2007 by the United States Patent and Trademark Office.	‌ Qlt Inc.	United States Patent and Trademark Office	7264629	September 4, 2007
‌ US Patent 7090691 Photodynamic therapy for the treatment of hair loss	Patent 7090691 was granted and assigned to Qlt Inc. on August, 2006 by the United States Patent and Trademark Office.	‌ Qlt Inc.	United States Patent and Trademark Office	7090691	August 15, 2006
‌ US Patent 7753943 Reduced fluence rate PDT	Patent 7753943 was granted and assigned to Qlt Inc. on July, 2010 by the United States Patent and Trademark Office.	‌ Qlt Inc.	United States Patent and Trademark Office	7753943	July 13, 2010
‌ US Patent 6890555 Liposome compositions of porphyrin photosensitizers	Patent 6890555 was granted and assigned to Qlt Inc. on May, 2005 by the United States Patent and Trademark Office.	‌ Qlt Inc.	United States Patent and Trademark Office	6890555	May 10, 2005
‌ US Patent 7393869 Methods of using thiazolidine derivatives to treat cancer or inflammation	Patent 7393869 was granted and assigned to Qlt Inc. on July, 2008 by the United States Patent and Trademark Office.	‌ Qlt Inc.	United States Patent and Trademark Office	7393869	July 1, 2008
‌ US Patent 7455858 Compositions and methods for delivery of photosensitive drugs	Patent 7455858 was granted and assigned to Qlt Inc. on November, 2008 by the United States Patent and Trademark Office.	‌ Qlt Inc.	United States Patent and Trademark Office	7455858	November 25, 2008
‌ US Patent 8333726 Lacrimal implants and related methods	Patent 8333726 was granted and assigned to Qlt Inc. on December, 2012 by the United States Patent and Trademark Office.	‌ Qlt Inc.	United States Patent and Trademark Office	8333726	December 18, 2012
‌ US Patent 7678829 Oculoselective drugs and prodrugs	Patent 7678829 was granted and assigned to Qlt Inc. on March, 2010 by the United States Patent and Trademark Office.	‌ Qlt Inc.	United States Patent and Trademark Office	7678829	March 16, 2010
‌ US Patent 7288556 Antiproliferative 1,2,3-thiadiazole compounds	Patent 7288556 was granted and assigned to Qlt Inc. on October, 2007 by the United States Patent and Trademark Office.	‌ Qlt Inc.	United States Patent and Trademark Office	7288556	October 30, 2007
‌ US Patent 8210902 Surface treated implantable articles and related methods	Patent 8210902 was granted and assigned to Qlt Inc. on July, 2012 by the United States Patent and Trademark Office.	‌ Qlt Inc.	United States Patent and Trademark Office	8210902	July 3, 2012
‌ US Patent 7122568 Use of low-dose PDT to inhibit restenosis	Patent 7122568 was granted and assigned to Qlt Inc. on October, 2006 by the United States Patent and Trademark Office.	‌ Qlt Inc.	United States Patent and Trademark Office	7122568	October 17, 2006
‌ US Patent 8158669 Method for treating neovascularization	Patent 8158669 was granted and assigned to Qlt Inc. on April, 2012 by the United States Patent and Trademark Office.	‌ Qlt Inc.	United States Patent and Trademark Office	8158669	April 17, 2012
‌ US Patent 7135193 Liposome compositions of porphyrin photosensitizers	Patent 7135193 was granted and assigned to Qlt Inc. on November, 2006 by the United States Patent and Trademark Office.	‌ Qlt Inc.	United States Patent and Trademark Office	7135193	November 14, 2006
‌ US Patent 7105503 Pyrazole compounds	Patent 7105503 was granted and assigned to Qlt Inc. on September, 2006 by the United States Patent and Trademark Office.	‌ Qlt Inc.	United States Patent and Trademark Office	7105503	September 12, 2006
‌ US Patent 7922702 Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device	Patent 7922702 was granted and assigned to Qlt Inc. on April, 2011 by the United States Patent and Trademark Office.	‌ Qlt Inc.	United States Patent and Trademark Office	7922702	April 12, 2011
‌ US Patent 7678775 ILK inhibitors for the treatment of renal disease	Patent 7678775 was granted and assigned to Qlt Inc. on March, 2010 by the United States Patent and Trademark Office.	‌ Qlt Inc.	United States Patent and Trademark Office	7678775	March 16, 2010
‌ US Patent 9173856 Therapeutic regimen and methods for treating or ameliorating visual disorders associated with an endogenous retinoid deficiency	Patent 9173856 was granted and assigned to Qlt Inc. on November, 2015 by the United States Patent and Trademark Office.	‌ Qlt Inc.	United States Patent and Trademark Office	9173856	November 3, 2015
‌ US Patent 6984395 Drug delivery system for hydrophobic drugs	Patent 6984395 was granted and assigned to Qlt Inc. on January, 2006 by the United States Patent and Trademark Office.	‌ Qlt Inc.	United States Patent and Trademark Office	6984395	January 10, 2006
‌ US Patent 6849058 Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases	Patent 6849058 was granted and assigned to Qlt Inc. on February, 2005 by the United States Patent and Trademark Office.	‌ Qlt Inc.	United States Patent and Trademark Office	6849058	February 1, 2005
‌ US Patent 7015240 Treatment of macular edema	Patent 7015240 was granted and assigned to Qlt Inc. on March, 2006 by the United States Patent and Trademark Office.	‌ Qlt Inc.	United States Patent and Trademark Office	7015240	March 21, 2006
‌ US Patent 7022702 Antiproliferative 1,2,3-thiadiazole compounds	Patent 7022702 was granted and assigned to Qlt Inc. on April, 2006 by the United States Patent and Trademark Office.	‌ Qlt Inc.	United States Patent and Trademark Office	7022702	April 4, 2006
‌ US Patent 7060695 Method to prevent vision loss	Patent 7060695 was granted and assigned to Qlt Inc. on June, 2006 by the United States Patent and Trademark Office.	‌ Qlt Inc.	United States Patent and Trademark Office	7060695	June 13, 2006

Results per page:

25 results

0 selected

25 results

0 selected